Improving Survivorship Among Minority Cancer Dyads

Breast Cancer Clinical Trial

Official title:

Improving Survivorship Outcomes for African American and Latinx Cancer Survivors and Caregiver Dyads Through A Culturally Based Training Program for Underserved Health Professional Students

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT04685551
• Other study ID #: CancerDyads
• Status: Withdrawn
• Phase: N/A
• Start date: July 1, 2021
• Est. completion date: December 31, 2024

Study information

• Verified date: July 2022
• Source: Charles Drew University of Medicine and Science
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This proposed intervention centers on improving survivorship outcomes among African American and Latinx cancer survivor and caregiver dyads. As a result, there will be four major outcomes. First, as a result of partnership with minority social institutions (e.g. faith leaders), we will develop an in-depth culturally sensitive curriculum and survivorship care plan for Cancer Survivorship and Caregiver Leaders Aimed for Minority Populations (CSC LAMPs). Second, we will increase knowledge and skills by evaluating a comprehensive cancer survivorship training program designed for underserved health professional students. Third, the implementation of this program will improve survivorship outcomes among African American and Latinx cancer survivors with advanced stage cancer and their caregivers. Lastly, this study will build sustainability for underserved minorities with the training of 30 future healthcare providers as a valuable community resource for improving cancer survivorship outcomes. The long-term outcomes of the CSC LAMPs program will generate workforce capacity and diversity in cancer-based clinical practice, research, and community advocacy for underserved minority cancer survivors and caregivers.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: December 31, 2024
• Est. primary completion date: June 30, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Aim 1 Focus Group for Cancer Survivors and Caregivers:

Inclusion Criteria

• Individuals ages 18 and older

• identify as African American or Latinx

• identify as a cancer survivor and/or caregiver

• speak and/or understand English

Exclusion Criteria

• individuals ages 17 years or younger

• does not identify as African American or Latinx

• unable to speak or understand English

• does not identify as a cancer survivor or caregiver

Aim 1 Focus Group for Oncology Healthcare Providers:

Inclusion Criteria

• Individuals ages 18 and older

• identify as a healthcare provider

• provide care to cancer patients in current provider role

• speak and/or understand English

Exclusion Criteria

• individuals ages 17 years or younger

• unable to speak or understand English

• does not provide care to cancer patients

• does not identify as a healthcare provider

Aim 2:

Inclusion Criteria

• Individuals ages 18 and older

• registered as a CDU student

• speak and/or understand English

• considered to be underserved, which include a) identifying as an underrepresented minority: Asian, Pacific Islander, African American, Hispanic, and Native American/Alaskan Native and/or b) from a medically underserved population (i.e. faced economic, cultural or linguistic barriers to health care)

Exclusion Criteria

• individuals ages 17 years or younger

• not registered as a CDU student

• unable to speak or understand English

• not considered to be underserved

For Aim 3:

Inclusion Criteria

• cancer survivor with a participating caregiver

• stage III or stage IV cancer diagnosis

• breast, lung, or colorectal cancer diagnosis

• identify as African American or Latinx

• speak and/or understand English

Exclusion Criteria

• individuals ages 17 years or younger

• does not identify as African American or Latinx

• unable to speak or understand English

• does not identify as a cancer survivor

• cancer survivor does not identify a caregiver

• does not have a breast, lung, or colorectal cancer diagnosis

• not diagnosed with a stage III or stage IV cancer diagnosis

Related Conditions & MeSH terms

• Breast Cancer
• Cancer
• Caregiver Burden
• Caregiver Burnout
• Colon Cancer
• Lung Cancer

Intervention

Behavioral:
• Change in knowledge, motivation, skills, and resources
Provide/enhance knowledge, modify attitudes, motivate and provide skills and resources to improve survivorship outcomes.

Locations

Country	Name	City	State
United States	Charles R. Drew University of Medicine & Science	Los Angeles	California

Sponsors (1)

Lead Sponsor	Collaborator
Charles Drew University of Medicine and Science

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Increase in psychosocial well-being using the Quality of Life: Short Form Health Survey and the Center for Epidemiologic Studies Depression Scale	By comparison from baseline to post-intervention, there will be a 25% increase in the psychosocial well-being among study participants.	3 months
Primary	Reduction of barriers to symptom management Using the Symptom Distress Scale survey	By comparison from baseline to post-intervention, there will be a 25% decrease in the barriers to symptom management among study participants.	3 months
Primary	3. Decrease in unmet needs Using the Barriers to Follow-Up Care Survey and Cancer Survivors Unmet Needs instrument	By comparison from baseline to post-intervention, there will be a 25% decrease in the unmet needs among study participants.	3 months
Primary	Reduction in caregiver burden using the Caregiver reaction assessment (CRA) survey	By comparison from baseline to post-intervention, there will be a 25% decrease in the caregiver burden among study participants.	3 months
Primary	5. Increase knowledge and utilization of supportive services using the Medical Outcomes Study Social Support Survey	By comparison from baseline to post-intervention, there will be a 25% increase in the knowledge and utilization of supportive services among study participants.	3 months